Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Owens

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 11, 2016
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsMarkolf Hanefeld, Louis Monnier, Oliver Schnell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 2, 2003
Self-injury attendances in the accident and emergency department: Clinical database studyJudith Horrocks, Sally Price, Allan House, et al.
Pediatrics|July 5, 2005
Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorderLoren K Mell, Robert L Davis, David Owens
Journal of the Intensive Care Society|October 6, 2017
Poorly placed tracheostomy tubes: Effects on flow and resistanceJoshua Moorhouse, Tahir Ali, Tobias Moorhouse, et al.
Crisis|November 21, 2014
Suicide after nonfatal self-harmEleni Karasouli, David Owens, Gary Latchford, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2014
Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanismsA Hari Kishore, David Owens, R Ann Word
Diabetes Technology & Therapeutics|May 13, 2011
The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetesLouis Monnier, Anne Wojtusciszyn, Claude Colette, et al.
Diabetes Care|October 31, 2013
Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes Care|June 26, 2014
Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|September 21, 2021
Glycaemic variabilities: Key questions in pursuit of clarityL Ouis Monnier, David Owens, Claude Colette, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 11, 2016
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsMarkolf Hanefeld, Louis Monnier, Oliver Schnell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 2, 2003
Self-injury attendances in the accident and emergency department: Clinical database studyJudith Horrocks, Sally Price, Allan House, et al.
Pediatrics|July 5, 2005
Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorderLoren K Mell, Robert L Davis, David Owens
Journal of the Intensive Care Society|October 6, 2017
Poorly placed tracheostomy tubes: Effects on flow and resistanceJoshua Moorhouse, Tahir Ali, Tobias Moorhouse, et al.
Crisis|November 21, 2014
Suicide after nonfatal self-harmEleni Karasouli, David Owens, Gary Latchford, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2014
Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanismsA Hari Kishore, David Owens, R Ann Word
Diabetes Technology & Therapeutics|May 13, 2011
The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetesLouis Monnier, Anne Wojtusciszyn, Claude Colette, et al.
Diabetes Care|October 31, 2013
Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes Care|June 26, 2014
Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|September 21, 2021
Glycaemic variabilities: Key questions in pursuit of clarityL Ouis Monnier, David Owens, Claude Colette, et al.
Pageof 13